Literature DB >> 15632884

Impact of female sex on outcome after percutaneous coronary intervention.

John H Chiu1, Deepak L Bhatt, Khaled M Ziada, Derek P Chew, Patrick L Whitlow, A Michael Lincoff, Stephen G Ellis, Eric J Topol.   

Abstract

BACKGROUND: Prior reports have suggested that women have increased mortality compared to men following percutaneous coronary intervention (PCI). It remains unclear if this difference is secondary to sex or other confounding variables.
METHODS: We sought to examine the characteristics and outcomes of 18039 consecutive women and men undergoing PCI at The Cleveland Clinic Foundation from 1992-2002.
RESULTS: Procedural success rates were similar in both sexes, but the female cohort had a greater incidence of access site hematoma (5% vs. 2%, P < .0001) and blood product transfusion (12% vs. 4%, P < .0001) following PCI. The rate of myocardial infarction (MI) at 1 year was slightly higher among females (10% vs. 9%, P = .004), but revascularization rates were not significantly different between sexes. One-year mortality was also higher in the female cohort (7% vs. 5%, P < .0001). After adjustment in a multivariate model, the Cox proportional hazard ratio for mortality in females was 1.01 (95% CI 0.93-1.11, P = .78). The hazard ratio for the combined endpoint of death or MI was 1.05 (95% CI 0.97-1.13, P = .23).
CONCLUSIONS: After adjustment for differences in comorbidities, the risk for long-term mortality is not significantly different between sexes following PCI. However, there is a greater incidence of post-procedural bleeding complications among women.

Entities:  

Mesh:

Year:  2004        PMID: 15632884     DOI: 10.1016/j.ahj.2004.05.045

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Gender gap in acute coronary heart disease: Myth or reality?

Authors:  Mette Claassen; Kirsten C Sybrandy; Yolande E Appelman; Folkert W Asselbergs
Journal:  World J Cardiol       Date:  2012-02-26

2.  Sex Differences in 1-Year Outcomes After Percutaneous Coronary Intervention in the Veterans Health Administration.

Authors:  Melissa M Farmer; Maggie A Stanislawski; Mary E Plomondon; Bevanne Bean-Mayberry; Nataria T Joseph; Lauren E Thompson; Jessica L Zuchowski; Stacie L Daugherty; Elizabeth M Yano; P Michael Ho
Journal:  J Womens Health (Larchmt)       Date:  2017-05-12       Impact factor: 2.681

3.  Gender differences in the association between discharge hemoglobin and 12-month mortality after acute myocardial infarction.

Authors:  Lauren E Thompson; Frederick A Masoudi; Kensey L Gosch; Pamela N Peterson; Philip G Jones; Adam C Salisbury; Mikhail Kosiborod; Stacie L Daugherty
Journal:  Clin Cardiol       Date:  2017-12-16       Impact factor: 2.882

4.  Gender differences in in-hospital clinical outcomes after percutaneous coronary interventions: an insight from a Japanese multicenter registry.

Authors:  Yohei Numasawa; Shun Kohsaka; Hiroaki Miyata; Shigetaka Noma; Masahiro Suzuki; Shiro Ishikawa; Iwao Nakamura; Yutaro Nishi; Takahiro Ohki; Koji Negishi; Toshiyuki Takahashi; Keiichi Fukuda
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

5.  Influence of sex on outcomes after percutaneous coronary intervention in patients over 75 years of age with coronary heart disease.

Authors:  Yuqi Liu; Xin Hu; Qiao Xue; Yusheng Zhao; Yu Wang; Lei Gao
Journal:  Clin Interv Aging       Date:  2014-10-23       Impact factor: 4.458

6.  The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials).

Authors:  David S Eccleston; Joseph M Kim; Jurien M Ten Berg; P Gabriel Steg; Deepak L Bhatt; Stefan H Hohnloser; Anne de Veer; Matias Nordaby; Corinna Miede; Takeshi Kimura; Gregory Y H Lip; Jonas Oldgren; Christopher P Cannon
Journal:  Clin Cardiol       Date:  2021-05-27       Impact factor: 2.882

7.  Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial.

Authors:  Michelle L O'Donoghue; Deepak L Bhatt; Gregg W Stone; Ph Gabriel Steg; C Michael Gibson; Christian W Hamm; Matthew J Price; Jayne Prats; Tiepu Liu; Efthymios N Deliargyris; Kenneth W Mahaffey; Harvey D White; Robert A Harrington
Journal:  Circulation       Date:  2016-01-19       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.